Form 13-F position report

TENET HEALTHCARE CORP

Reported by Huber Capital Management LLC

THC CUSIP 88033G407 Manager CIK 0001511697

Reported 76,901 shares, up 1,600 (2.1%) from the prior quarter.

Reported value 39.5%; share count 2.1% vs. the prior quarter.

Added
% of reported 13F value 2.92% This manager · Q3 2026
Shares 76,901 Quarter-end amount reported
Reported value $19,652,820 Fair value at quarter end
Consecutive quarters held 54 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1569000
2022-03-31 1608000
2022-06-30 1304000
2022-09-30 867000
2022-12-31 1117340
2023-03-31 1241937
2023-06-30 1562577
2023-09-30 1265154
2023-12-31 937144
2024-03-31 1303469
2024-06-30 1396948
2024-09-30 1745266
2024-12-31 1401279
2025-03-31 5420485
2025-06-30 7444976
2025-09-30 10416155
2025-12-31 11983015
2026-03-31 11945532
2026-06-30 14087311
2026-09-30 19652820

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for TENET HEALTHCARE CORP held by Huber Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 76,901 +1,600 (2.1%) 2.92% $19,652,820 2026-11-12
Q2 2026 Added 75,301 +12,000 (19.0%) 2.08% $14,087,311 2026-08-12
Q1 2026 Added 63,301 +3,000 (5.0%) 1.85% $11,945,532 2026-05-12
Q4 2025 Added 60,301 +9,000 (17.5%) 1.76% $11,983,015 2026-02-13
Q3 2025 Added 51,301 +9,000 (21.3%) 1.65% $10,416,155 2025-11-13
Q2 2025 Added 42,301 +2,000 (5.0%) 1.27% $7,444,976 2025-08-13
Q1 2025 Added 40,301 +29,200 (263.0%) 1.02% $5,420,485 2025-05-14
Q4 2024 Added 11,101 +600 (5.7%) 0.28% $1,401,279 2025-02-12
Q3 2024 Unchanged 10,501 0 (0.0%) 0.35% $1,745,266 2024-11-13
Q2 2024 Reduced 10,501 -1,900 (-15.3%) 0.32% $1,396,948 2024-08-13
Q1 2024 Unchanged 12,401 0 (0.0%) 0.29% $1,303,469 2024-05-14
Q4 2023 Reduced 12,401 -6,800 (-35.4%) 0.24% $937,144 2024-02-13
Q3 2023 Unchanged 19,201 0 (0.0%) 0.3% $1,265,154 2023-11-13
Q2 2023 Reduced 19,201 -1,700 (-8.1%) 0.38% $1,562,577 2023-08-11
Q1 2023 Reduced 20,901 -2,000 (-8.7%) 0.31% $1,241,937 2023-05-12
Q4 2022 Added 22,901 +6,100 (36.3%) 0.28% $1,117,340 2023-02-13
Q3 2022 Reduced 16,801 -8,000 (-32.3%) 0.24% $867,000 2022-11-14
Q2 2022 Added 24,801 +6,100 (32.6%) 0.36% $1,304,000 2022-08-12
Q1 2022 Reduced 18,701 -500 (-2.6%) 0.4% $1,608,000 2022-05-13
Q4 2021 Reduced 19,201 -1,600 (-7.7%) 0.41% $1,569,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

840 managers reported TENET HEALTHCARE CORP for Q3 2026.

Managers reporting TENET HEALTHCARE CORP in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 8,361,497 -381,508 0.03% $2,136,864,103 9 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 6,683,850 -1,273,599 0.17% $1,708,126,000 54 qtrs
Boston Partners Reduced 4,064,662 -368,698 0.93% $1,039,037,702 17 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 4,002,846 -235,262 0.05% $1,022,967,324 3 qtrs
FMR LLC Reduced 3,924,252 -70,293 0.04% $1,002,881,749 54 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 3,621,770 -272,419 0.02% $925,579,541 3 qtrs
STATE STREET CORPORATION Reduced 2,650,621 -100,669 0.02% $677,392,703 54 qtrs
GLENVIEW CAPITAL MANAGEMENT LLC Reduced 2,047,843 -187,823 8.54% $523,346,757 54 qtrs
CITADEL ADVISORS LLC Reduced 1,748,920 -16,676 0.05% $446,953,995 54 qtrs
ARROWSTREET CAPITAL LIMITED PARTNERSHIP Reduced 1,655,293 -53,160 0.18% $423,026,679 18 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 12, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
76,901
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.